Racial disparity in metabolic regulation of cancer

Kuldeep S. Attri, Divya Murthy, Pankaj Singh

Research output: Contribution to journalReview article

2 Citations (Scopus)

Abstract

Genetic mutations and metabolic reprogramming are two key hallmarks of cancer, required for proliferation, invasion, and metastasis of the disease. While genetic mutations, whether inherited or acquired, are critical for the initiation of tumor development, metabolic reprogramming is an effector mechanism imperative for adaptational transition during the progression of cancer. Recent findings in the literature emphasize the significance of molecular cross-talk between these two cellular processes in regulating signaling and differentiation of cancer cells. Genome-wide sequencing analyses of cancer genomes have highlighted the association of various genic mutations in predicting cancer risk and survival. Oncogenic mutational frequency is heterogeneously distributed among various cancer types in different populations, resulting in varying susceptibility to cancer risk. In this review, we explore and discuss the role of genetic mutations in metabolic enzymes and metabolic oncoregulators to stratify cancer risk in persons of different racial backgrounds.

Original languageEnglish (US)
Pages (from-to)1221-1246
Number of pages26
JournalFrontiers in Bioscience - Landmark
Volume22
Issue number8
DOIs
StatePublished - Mar 1 2017

Fingerprint

Genes
Neoplasms
Tumors
Mutation
Cells
Enzymes
Genome
Cell Differentiation
Neoplasm Metastasis
Survival
Population

Keywords

  • Cancer
  • Ethnic
  • Metabolism
  • Mutation
  • Oncogene
  • Oncometabolite
  • Race
  • Tumor suppressor

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)
  • Immunology and Microbiology(all)

Cite this

Racial disparity in metabolic regulation of cancer. / Attri, Kuldeep S.; Murthy, Divya; Singh, Pankaj.

In: Frontiers in Bioscience - Landmark, Vol. 22, No. 8, 01.03.2017, p. 1221-1246.

Research output: Contribution to journalReview article

Attri, Kuldeep S. ; Murthy, Divya ; Singh, Pankaj. / Racial disparity in metabolic regulation of cancer. In: Frontiers in Bioscience - Landmark. 2017 ; Vol. 22, No. 8. pp. 1221-1246.
@article{40a0eababc834b9cbb35d5805435fa2d,
title = "Racial disparity in metabolic regulation of cancer",
abstract = "Genetic mutations and metabolic reprogramming are two key hallmarks of cancer, required for proliferation, invasion, and metastasis of the disease. While genetic mutations, whether inherited or acquired, are critical for the initiation of tumor development, metabolic reprogramming is an effector mechanism imperative for adaptational transition during the progression of cancer. Recent findings in the literature emphasize the significance of molecular cross-talk between these two cellular processes in regulating signaling and differentiation of cancer cells. Genome-wide sequencing analyses of cancer genomes have highlighted the association of various genic mutations in predicting cancer risk and survival. Oncogenic mutational frequency is heterogeneously distributed among various cancer types in different populations, resulting in varying susceptibility to cancer risk. In this review, we explore and discuss the role of genetic mutations in metabolic enzymes and metabolic oncoregulators to stratify cancer risk in persons of different racial backgrounds.",
keywords = "Cancer, Ethnic, Metabolism, Mutation, Oncogene, Oncometabolite, Race, Tumor suppressor",
author = "Attri, {Kuldeep S.} and Divya Murthy and Pankaj Singh",
year = "2017",
month = "3",
day = "1",
doi = "10.2741/4543",
language = "English (US)",
volume = "22",
pages = "1221--1246",
journal = "Frontiers in Bioscience - Landmark",
issn = "1093-9946",
publisher = "Frontiers in Bioscience",
number = "8",

}

TY - JOUR

T1 - Racial disparity in metabolic regulation of cancer

AU - Attri, Kuldeep S.

AU - Murthy, Divya

AU - Singh, Pankaj

PY - 2017/3/1

Y1 - 2017/3/1

N2 - Genetic mutations and metabolic reprogramming are two key hallmarks of cancer, required for proliferation, invasion, and metastasis of the disease. While genetic mutations, whether inherited or acquired, are critical for the initiation of tumor development, metabolic reprogramming is an effector mechanism imperative for adaptational transition during the progression of cancer. Recent findings in the literature emphasize the significance of molecular cross-talk between these two cellular processes in regulating signaling and differentiation of cancer cells. Genome-wide sequencing analyses of cancer genomes have highlighted the association of various genic mutations in predicting cancer risk and survival. Oncogenic mutational frequency is heterogeneously distributed among various cancer types in different populations, resulting in varying susceptibility to cancer risk. In this review, we explore and discuss the role of genetic mutations in metabolic enzymes and metabolic oncoregulators to stratify cancer risk in persons of different racial backgrounds.

AB - Genetic mutations and metabolic reprogramming are two key hallmarks of cancer, required for proliferation, invasion, and metastasis of the disease. While genetic mutations, whether inherited or acquired, are critical for the initiation of tumor development, metabolic reprogramming is an effector mechanism imperative for adaptational transition during the progression of cancer. Recent findings in the literature emphasize the significance of molecular cross-talk between these two cellular processes in regulating signaling and differentiation of cancer cells. Genome-wide sequencing analyses of cancer genomes have highlighted the association of various genic mutations in predicting cancer risk and survival. Oncogenic mutational frequency is heterogeneously distributed among various cancer types in different populations, resulting in varying susceptibility to cancer risk. In this review, we explore and discuss the role of genetic mutations in metabolic enzymes and metabolic oncoregulators to stratify cancer risk in persons of different racial backgrounds.

KW - Cancer

KW - Ethnic

KW - Metabolism

KW - Mutation

KW - Oncogene

KW - Oncometabolite

KW - Race

KW - Tumor suppressor

UR - http://www.scopus.com/inward/record.url?scp=85031394891&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85031394891&partnerID=8YFLogxK

U2 - 10.2741/4543

DO - 10.2741/4543

M3 - Review article

C2 - 28199202

AN - SCOPUS:85031394891

VL - 22

SP - 1221

EP - 1246

JO - Frontiers in Bioscience - Landmark

JF - Frontiers in Bioscience - Landmark

SN - 1093-9946

IS - 8

ER -